久光製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2020/04/30 | 5,270 | 5,280 | 5,070 | 5,080 | -90 | -1.7% | 201,400 |
2020/04/28 | 5,140 | 5,190 | 5,040 | 5,170 | +110 | +2.2% | 133,600 |
2020/04/27 | 4,975 | 5,060 | 4,960 | 5,060 | +120 | +2.4% | 146,200 |
2020/04/24 | 4,980 | 5,000 | 4,900 | 4,940 | -40 | -0.8% | 152,400 |
2020/04/23 | 4,945 | 5,010 | 4,880 | 4,980 | +45 | +0.9% | 105,300 |
2020/04/22 | 4,815 | 4,945 | 4,795 | 4,935 | +85 | +1.8% | 115,300 |
2020/04/21 | 4,875 | 4,925 | 4,830 | 4,850 | -80 | -1.6% | 171,000 |
2020/04/20 | 4,855 | 4,950 | 4,825 | 4,930 | -65 | -1.3% | 131,300 |
2020/04/17 | 5,090 | 5,160 | 4,965 | 4,995 | -5 | -0.1% | 148,000 |
2020/04/16 | 4,970 | 5,040 | 4,950 | 5,000 | -30 | -0.6% | 148,700 |
2020/04/15 | 4,940 | 5,060 | 4,910 | 5,030 | +75 | +1.5% | 176,100 |
2020/04/14 | 4,940 | 5,020 | 4,880 | 4,955 | +25 | +0.5% | 208,600 |
2020/04/13 | 4,750 | 4,965 | 4,685 | 4,930 | -60 | -1.2% | 237,400 |
2020/04/10 | 4,920 | 5,020 | 4,725 | 4,990 | +120 | +2.5% | 222,600 |
2020/04/09 | 5,000 | 5,020 | 4,755 | 4,870 | -140 | -2.8% | 129,000 |
2020/04/08 | 4,825 | 5,040 | 4,825 | 5,010 | +185 | +3.8% | 135,600 |
2020/04/07 | 4,775 | 4,855 | 4,670 | 4,825 | +120 | +2.6% | 165,800 |
2020/04/06 | 4,645 | 4,730 | 4,520 | 4,705 | +150 | +3.3% | 139,900 |
2020/04/03 | 4,555 | 4,770 | 4,505 | 4,555 | -35 | -0.8% | 146,100 |
2020/04/02 | 4,755 | 4,830 | 4,550 | 4,590 | -135 | -2.9% | 175,200 |
2020/04/01 | 4,980 | 5,050 | 4,695 | 4,725 | -315 | -6.3% | 199,300 |
2020/03/31 | 5,390 | 5,400 | 5,010 | 5,040 | -330 | -6.1% | 203,800 |
2020/03/30 | 5,200 | 5,380 | 5,080 | 5,370 | +150 | +2.9% | 221,400 |
2020/03/27 | 5,390 | 5,390 | 5,010 | 5,220 | +50 | +1% | 352,300 |
2020/03/26 | 4,965 | 5,210 | 4,855 | 5,170 | +195 | +3.9% | 259,600 |
2020/03/25 | 4,750 | 4,975 | 4,715 | 4,975 | +470 | +10.4% | 210,900 |
2020/03/24 | 4,960 | 5,020 | 4,440 | 4,505 | -190 | -4% | 232,100 |
2020/03/23 | 4,550 | 4,710 | 4,470 | 4,695 | +170 | +3.8% | 288,700 |
2020/03/19 | 4,555 | 4,660 | 4,470 | 4,525 | +180 | +4.1% | 431,200 |
2020/03/18 | 4,250 | 4,550 | 4,205 | 4,345 | +165 | +3.9% | 330,700 |
2020/03/17 | 3,805 | 4,225 | 3,775 | 4,180 | +270 | +6.9% | 322,700 |
2020/03/16 | 4,010 | 4,150 | 3,890 | 3,910 | -50 | -1.3% | 198,200 |
2020/03/13 | 3,870 | 4,045 | 3,725 | 3,960 | -190 | -4.6% | 256,800 |
2020/03/12 | 4,220 | 4,255 | 4,095 | 4,150 | -175 | -4% | 230,300 |
2020/03/11 | 4,385 | 4,455 | 4,325 | 4,325 | -105 | -2.4% | 157,600 |
2020/03/10 | 4,400 | 4,460 | 4,175 | 4,430 | +95 | +2.2% | 212,000 |
2020/03/09 | 4,440 | 4,450 | 4,280 | 4,335 | -220 | -4.8% | 145,900 |
2020/03/06 | 4,640 | 4,640 | 4,530 | 4,555 | -150 | -3.2% | 145,800 |
2020/03/05 | 4,795 | 4,795 | 4,655 | 4,705 | +5 | +0.1% | 198,800 |
2020/03/04 | 4,700 | 4,750 | 4,655 | 4,700 | -90 | -1.9% | 127,300 |
2020/03/03 | 4,950 | 4,965 | 4,785 | 4,790 | -105 | -2.1% | 210,300 |
2020/03/02 | 4,705 | 4,935 | 4,705 | 4,895 | +60 | +1.2% | 202,000 |
2020/02/28 | 4,830 | 4,870 | 4,750 | 4,835 | -135 | -2.7% | 259,500 |
2020/02/27 | 5,040 | 5,040 | 4,950 | 4,970 | -170 | -3.3% | 152,500 |
2020/02/26 | 5,160 | 5,160 | 5,060 | 5,140 | -90 | -1.7% | 225,900 |
2020/02/25 | 5,270 | 5,310 | 5,200 | 5,230 | -340 | -6.1% | 290,400 |
2020/02/21 | 5,520 | 5,610 | 5,520 | 5,570 | +40 | +0.7% | 124,200 |
2020/02/20 | 5,570 | 5,630 | 5,520 | 5,530 | +10 | +0.2% | 128,600 |
2020/02/19 | 5,510 | 5,540 | 5,490 | 5,520 | +70 | +1.3% | 103,800 |
2020/02/18 | 5,590 | 5,590 | 5,430 | 5,450 | -160 | -2.9% | 155,500 |
1301~
1350
件表示中 / 3768件
類似銘柄と比較する
現在ご覧いただいている「久光薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
久光薬 | 429,900円 | +5.8% | +1.2% | 2.79% | 13.92倍 | 1.11倍 |
|
貼る鎮痛消炎剤首位。医療用シェア5割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
住友ファーマ | 144,000円 | -11.0% | +206.6% | 0.00% | 14.30倍 | 3.38倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
参天薬 | 157,500円 | -2.0% | -7.3% | 2.41% | 15.39倍 | 1.83倍 |
|
緑内障、加齢黄斑変性、ドライアイ治療薬など眼科用医薬品首位。一般用目薬「サンテ」が有名 |
ツムラ | 364,900円 | +3.8% | -19.9% | 3.73% | 11.85倍 | 0.91倍 |
|
医療用漢方薬で国内シェア8割超。高齢者、がん支持療法、女性関連の3領域を重点に市場深耕 |
日本新薬 | 322,600円 | +3.6% | -15.3% | 3.84% | 9.06倍 | 0.88倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
市場注目の銘柄
チャート関連のコラム